Ryman Healthcare Ltd (NZSE:RYM)
NZ$ 3.64 -0.02 (-0.55%) Market Cap: 2.50 Bil Enterprise Value: 5.03 Bil PE Ratio: 522.86 PB Ratio: 0.57 GF Score: 59/100

Full Year 2021 Ryman Healthcare Ltd Earnings Call Transcript

May 20, 2021 / 10:00PM GMT
Release Date Price: NZ$13.56 (-1.44%)
David Kerr
Ryman Healthcare Limited - Independent Chairman of the Board

(foreign language) Good morning, everyone, and welcome to Ryman Healthcare's full year results presentation for the year to March 31, 2021. My name is David Kerr, and I'm the Chairman of Ryman Healthcare. To my right, we have Gordon MacLeod, our Chief Executive; and David Bennett, further down the table, our Chief Financial Officer.

So once again, we've opted to make the presentation a virtual event. We find this as best as an approach because it takes the guesswork out of which COVID level we are in.

I'm going to give you a brief overview of the year, an update on the COVID situation and impact, Gordy will give you his analysis of the year and growth plans and thoughts on what he sees ahead, and David will then give you some greater financial detail on our financial results. So we welcome questions at the end. You can ask questions either online or over the phone for those of you who've called in, and of course, you can contact us afterwards if there's anything else you'd like to know.

You'll see on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot